Effect of matrix metalloproteinase-9 knockout on vein graft remodelling in mice

Journal of Vascular Research

Volumn 47, Issue 4, 2010, Pages 299-308

  Thomas, Anita C ^a,b   Newby, Andrew C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Matrix metalloproteinases; MMP 2; MMP 9; Remodelling; Vein graft

Indexed keywords

COLLAGEN; GELATINASE A; GELATINASE B;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PARAMETERS; CELL COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; VEIN GRAFT; VENOUS WALL THICKNESS;

ANIMALS; CELL PROLIFERATION; COLLAGEN; FEMALE; GRAFT OCCLUSION, VASCULAR; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; THROMBOSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA; UP-REGULATION; VASCULAR PATENCY; VENAE CAVAE;

EID: 72049111042     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265564     Document Type: Article

References (32)

1. Motwani JG, Topol EJ: Aortocoronary sa-phenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998; 97: 916-931.
2. Torsney E, Mayr U, Zou Y, Thompson WD, Hu Y, Xu Q: Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. Circ Res 20 04; 94: 1466-1473.
3. Thomas AC, Campbell JH: Timecourse of fibrin deposition and removal after arterial injury. Thromb Res 2003; 109: 65-69.
4. Newby AC: Dual role of matrix metallopro-teinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005; 85:1-31.
5. Fitzgerald M, Hayward IP, Thomas AC, Campbell GR, Campbell JH: Matrix metal-loproteinase can facilitate the heparanase-induced promotion of phenotype change in vascular smooth muscle cells. Atherosclerosis 1999; 145: 97-106.
6. Lijnen HR, van Hoef B, Lupu F, Moons L, Carmeliet P, Collen D: Function of the plas-minogen/plasmin and matrix metallopro-teinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 1998; 18:1035-1045.
7. Morishige K, Shimokawa H, Matsumoto Y, Eto Y, Uwatoku T, Abe K, Sueishi K, Takeshi-ta A: Overexpression of matrix metallopro-teinase-9 promotes intravascular thrombus formation in porcine coronary arteries in vivo. Cardiovasc Res 2003; 57:572-585.
8. Berceli SA, Jiang Z, Klingman NV, Pfahnl CL, Abouhamze ZS, Frase CD, Schultz GS, Ozaki CK: Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling. J Vasc Surg 2004; 39:1084-1090.
9. Mott JD, Werb Z: Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004; 16:558-564.
10. Lelongt B, Bengatta S, Delauche M, Lund LR, Werb Z, Ronco PM: Matrix metalloprotein-ase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. J Exp Med 2001; 193: 793-802.
11. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z: MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998; 93:411-422.
12. Gordon S: Alternative activation of macro-phages. Nat Rev Immunol 2003; 3:23-35.
13. Berceli SA, Jiang Z, Klingman NV, Schultz GS, Keith OC: Early differential MMP-2 and-9 dynamics during flow-induced arterial and vein graft adaptations. J Surg Res 2006; 134:327-334.
14. George SJ, Zaltsman AB, Newby AC: Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. Cardiovasc Res 1997; 33: 4 47-459.
15. Chesler NC, Ku DN, Galis ZS: Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo. Am J Physiol Heart Circ Physiol 1999; 277:H2002-H2009.
16. Sharony R, Pintucci G, Saunders PC, Grossi EA, Baumann FG, Galloway AC, Mignatti P: Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and-2. Am J Physiol Heart Circ Physiol 2006; 290:H1651-H1659.
17. Wong AP, Nili N, Jackson ZS, Qiang B, Le-ong-Poi H, Jaffe R, Raanani E, Connelly PW, Sparkes JD, Strauss BH: Expansive remodeling in venous bypass grafts: novel implications for vein graft disease. Atherosclerosis 2008; 196:580-589.
18. Hu Y, Baker AH, Zou Y, Newby AC, Xu Q: Local gene transfer of tissue inhibitor of me-talloproteinase-2 influences vein graft remodeling in a mouse model. Arterioscler Thromb Vasc Biol 2001; 21: 1275-1280.
19. Cho A, Reidy MA: Matrix metalloprotein-ase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 2002; 91: 845-851.
20. Johnson C, Galis ZS: Matrix metalloprotein-ase-2 and-9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol 2004; 24:54-60.
21. Ikonomidis JS, Barbour JR, Amani Z, Stroud RE, Herron AR, McClister DM, Camens SE, Lindsey ML, Mukherjee R, Spinale FG: Effects of deletion of the matrix metallopro-teinase 9 gene on development of murine thoracic aortic aneurysms. Circulation 2005; 112:I242-I248.
22. Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, Xu Q: Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998; 153:1301-1310.
23. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT: Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 2000; 106:55-62.
24. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E: Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002; 91: 852-859.
25. Lessner SM, Martinson DE, Galis ZS: Compensatory vascular remodeling during atherosclerotic lesion growth depends on matrix metalloproteinase-9 activity. Arterio-scler Thromb Vasc Biol 2004; 24: 2123-2129.
26. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT: Matrix metalloprotein-ases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002; 110: 625-632.
27. Esparza J, Kruse M, Lee J, Michaud M, Madri JA: MMP-2 null mice exhibit an early onset and severe experimental autoimmune en-cephalomyelitis due to an increase in MMP-9 expression and activity. FASEB J 2004; 18: 1682-1691.
28. Xia T, Akers K, Eisen AZ, Seltzer JL: Comparison of cleavage site specificity of gelatin-ases A and B using collagenous peptides. Biochim Biophys Acta 1996; 1293:259-266.
29. Thomas AC, Campbell JH: Contractile and cytoskeletal proteins of smooth muscle cells in rat, rabbit, and human arteries. Tissue Cell 2000; 32: 249-256.
30. Rahat MA, Marom B, Bitterman H, Weiss-Cerem L, Kinarty A, Lahat N: Hypoxia reduces the output of matrix metalloprotein-ase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association. J Leukocyte Biol 2006; 79: 706-718.
31. Grote K, Flach I, Luchtefeld M, Akin E, Holland SM, Drexler H, Schieffer B: Mechanical stretch enhances mRNA expression and pro-enzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 2003; 92: e80-e86.
32. Johnson JL, George SJ, Newby AC, Jackson CL: Divergent effects of matrix metallopro-teinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci USA 2005; 102: 15575-15580.